Cognitive-Behavioral Group Therapy versus Sertraline for Obsessive-Compulsive Disorder: Five-Year Follow-Up

C. Borges,E. Meyer,Y. Ferrão,F. Souza,M. B. Sousa,A. Cordioli

DOI: https://doi.org/10.1159/000322028

2011-05-04

Psychotherapy and Psychosomatics

Abstract:ated 5 years after the end of the initial randomized clinical trial. All subjects provided written informed consent that was approved by the institutional review board. The Yale-Brown Scale for Obsessive-Compulsive Symptoms (Y-BOCS) [5, 6] and the Clinical Global Impression scale – Severity (CGI-S, adapted version) [7] were used to assess the severity of OCD symptoms. The Beck Depression Inventory (BDI) [8, 9] and Beck Anxiety Inventory (BAI) [10, 11] were used to assess depressive and anxiety symptoms, respectively. Both patients treated with CBGT and those treated with sertraline showed a significant reduction in the severity of symptoms at the end of the treatments, and they maintained therapeutic gains 5 years after. We also verified that a significant group of patients who underwent CBGT (13; 62%) started taking antiobsessional medication (p ! 0.001); on the other hand, psychotherapy was given to the patients who had taken sertraline (8; 32%), but at a nonsignificant level (p = 0.084). A total of 10 patients (22%), 2 (9.5%) from the CBGT group and 8 (32%) from the sertraline group, had CBT in the 5-year follow-up period ( 2 = 3.06; p = 0.084). Almost 62% of all patients continued using or started using medication, and 41.5% started or continued undergoing CBT in the 5-year follow-up period. There was a significant increase in remissive patients (partial or full remission) in the sertraline group (p = 0.046); the same did not occur in the CBGT group (p = 0.083). Table 1 shows patients’ scores on the Y-BOCS, CGI, BAI and BDI, as well as the nonimprovement, partial remission, full remission and relapse at the time of the follow-up study. The Y-BOCS total score median rate of variation between the initial treatment trial and the 5-year follow-up in the CBGT group ( fig. 1 ) was a 42.9% increase, while in the sertraline group there was a reduction by 17% (U Wilcoxon-Mann-Whitney = 167.5; p = 0.036). Cognitive-behavioral therapy (CBT) and serotonin reuptake inhibitors (SRI) are the first-choice treatments for obsessive-compulsive disorder (OCD) [1, 2] . Cognitive-behavioral group therapy (CBGT) has effectiveness similar to one-to-one CBT [3] . Speculation still persists whether the CBT outcomes, and especially CBGT, are sustained in the long term and if there are differences between the outcomes of CBT and antiobsessional medication. The aim of the present study was to investigate whether the reduction in severity of OCD symptoms obtained with 12-weekly sessions of CBGT or with sertraline (100 mg/day) during the same period, in a randomized clinical trial, would be sustained over a 5-year period, as well as to compare the differences between the 2 treatments in the long term. The randomized clinical trial in which patients were treated has been described in detail elsewhere [4] . Forty-six patients (92% of the initial sample) who were treated with CBGT (n = 21; 46%) or sertraline (n = 25; 54%) were evaluReceived: June 25, 2010 Accepted after revision: October 6, 2010 Published online: May 4, 2011